<DOC>
	<DOCNO>NCT02426866</DOCNO>
	<brief_summary>The purpose study determine whether increase risk cardiovascular event ( CV ) regimens contain efavirenz ( EFV ) versus regimens patient HIV .</brief_summary>
	<brief_title>Risk CV Events With EFV vs. EFV-free Regimens</brief_title>
	<detailed_description />
	<mesh_term>Efavirenz</mesh_term>
	<criteria>For information regard BMS clinical trial participation , please visit www.BMSStudyConnect.com Aged 18 year old index date Have least one pharmacy claim efavirenz drug comparison cohort period span January 1 , 2007 December 31,2013 . Clinical Modification ( ICD9 ) diagnosis code HIV infection include 042 ( HIV disease ) , V08 ( asymptomatic HIV infection status ) , 795.71 ( nonspecific serologic evidence HIV ) , 079.53 ( HIV , type 2 ) time prior index claim . Have least 6 month ( 180 day ) continuous enrollment prior index claim Patients dispense antiretroviral medication anytime index date include 180day baseline period Patients evidence cardiovascular outcome interest 180day baseline period</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2015</verification_date>
</DOC>